SEC Form 4 · accession 0001650131-26-000011
Mirum Pharmaceuticals, Inc. · MIRM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Radovich
Officer — PRESIDENT AND COO
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001759425
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 5, 2026 | M | 16,988 | $19.19 | A | 57,260 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $19.19 | Jun 5, 2026 | M | 16,988 | D | — | Jan 6, 2031 | Common Stock | 16,988 | 48,012 | D |
Explanation of responses
- F1The stock option is fully vested.